@article {1328884,
	title = {Understanding the evolving phenotype of vascular complications in telomere biology disorders},
	journal = {Angiogenesis},
	volume = {22},
	number = {1},
	year = {2019},
	month = {2019 Feb},
	pages = {95-102},
	abstract = {Vascular complications such as bleeding due to gastrointestinal telangiectatic anomalies, pulmonary arteriovenous malformations, hepatopulmonary syndrome, and retinal vessel abnormalities are being reported in patients with telomere biology disorders (TBDs) more frequently than previously described. The international clinical care consortium of telomere-associated ailments and family support group Dyskeratosis Congenita Outreach, Inc. held a workshop on vascular abnormalities in the TBDs at the National Cancer Institute in October 2017. Clinicians and basic scientists reviewed current data on vascular complications, hypotheses for the underlying biology and developed new collaborations to address the etiology and clinical management of vascular complications in TBDs.},
	issn = {1573-7209},
	doi = {10.1007/s10456-018-9640-7},
	author = {Higgs, Cecilia and Crow, Yanick J and Adams, Denise M and Chang, Emmanuel and Hayes, Don and Herbig, Utz and Huang, James N and Himes, Ryan and Jajoo, Kunal and Johnson, F Brad and Reynolds, Susan D and Yonekawa, Yoshihiro and Armanios, Mary and Boulad, Farid and DiNardo, Courtney D and Dufour, Carlo and Goldman, Frederick D and Khan, Shakila and Kratz, Christian and Myers, Kasiani C and Raghu, Ganesh and Alter, Blanche P and Aubert, Geraldine and Bhala, Sonia and Cowen, Edward W and Dror, Yigal and El-Youssef, Mounif and Friedman, Bruce and Giri, Neelam and Helms Guba, Lisa and Khincha, Payal P and Lin, Tiffany F and Longhurst, Hilary and McReynolds, Lisa J and Nelson, Adam and Olson, Tim and Pariser, Anne and Perona, Rosario and Sasa, Ghadir and Schratz, Kristen and Simonetto, Douglas A and Townsley, Danielle and Michael Walsh and Stevens, Katherine and Agarwal, Suneet and Bertuch, Alison A and Savage, Sharon A and Clinical Care Consortium for Telomere-associated Ailments (CCCTAA)}
}
